HIGHLIGHTS
- who: Alessandro Miscioscia from the Department of Neuroscience DNS, School of Medicine, University of Padua, Via Giustiniani, , Padua, Veneto Region, Italy have published the paper: Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis, in the Journal: (JOURNAL)
- what: In agreement with literature data , the authors found that pRNFL thickness and GCIPL volume are significantly lower in untreated PPMS as compared to HC, further confirming that the analysis of retinal layers gives the chance of identifying atrophic changes that can be used as biomarkers . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.